Luc Zimmer is currently a Professor of neuropharmacology at the Faculty of Pharmacy and the Faculty of Medicine, University of Lyon, Lyon, France, and is a Pharmacologist at the University Hospital of Lyon, France (Université Claude Bernard Lyon 1 & Hospices Civils de Lyon). From 1986 to 1992, he received a pharmacist education at the University of Strasbourg, Strasbourg, France, and from 1993 to 1999, he completed training during his internship and residency in radiopharmacy and radiopharmacology at the Nuclear Medicine Department, University Hospital of Tours, Tours, France, and at the National Institute for Nuclear Sciences and Technology (INSTN), Saclay, France. He received his Pharm.D. degree in radiopharmacology and his Ph.D. degree in neuroscience from the University of Tours, Tours, France. He joined the Hospital University of Lyon in 1999 as a Nuclear Pharmacist and Pharmacologist at the CERMEP-imaging platform. After obtaining the authorization to direct research, he took a position of Senior Lecturer at the Faculty of Pharmacy, University of Lyon, France, in 2002. In 2005, he was promoted as a full-time Professor of pharmacology and founded a laboratory of neuropharmacology at the University of Lyon and the French National Center for Scientific Research (CNRS). Since April 2008, he has also been the Head of the Preclinical Department of the CERMEP-Imaging Platform (Animage). Zimmer is currently Head of the Laboratory Radiopharmaceutical and Neurochemical Biomarkers (BIORAN) belonging to the Lyon Neuroscience Research (University of Lyon, CNRS, and INSERM, the French Institute of Health and Medical Research). He is working in the area of brain molecular imaging, particularly in the field of the serotonin neurotransmission. His research interests include the development of novel PET radiopharmaceuticals for brain diagnostic imaging in mood disorders and neurodegenerative diseases.
Biography Updated on 15 October 2016